The Sontag Foundation

The Sontag Foundation is a private family foundation established in 2002 with a strategic focus on advancing brain cancer research. Founded by Rick and Susan Sontag, the foundation was motivated by Susan's personal experience with the disease. The Foundation is best known for its Distinguished Scientist Award (DSA), a $750,000 career development grant awarded to early career scientists in the USA and Canada conducting research related to brain cancer. The grantees have shown remarkable career success and have achieved academic promotions and prestigious leadership appointments in their institutions and professional societies. The foundation proudly sponsors researchers at almost every major institution in North America. Additionally, in 2014, the founders established The Brain Tumor Network, a non-profit organization that offers free individualized support to brain tumor patients, helping them overcome treatment obstacles, access quality healthcare, and navigate the clinical trial process. The Sontag Foundation's commitment to biotechnology and its efforts in supporting initiatives that make a significant impact in the lives of individuals, primarily in brain cancer research, demonstrates its dedication to addressing one of the most challenging and poorly understood diseases. As of now, there is no available information about the last investment and investors. Overall, The Sontag Foundation's targeted approach to funding brain cancer research through the Distinguished Scientist Award and providing support to patients via The Brain Tumor Network showcases its commitment to advancing the understanding and treatment of brain cancer.